Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Fosamprenavir in Pts With Hepatic Impairment

View source ↗

Summary

An update on a trial evaluating Fosamprenavir in HIV-infected patients with hepatic impairment, with results posted in June 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexiva (fosamprenavir) (fosamprenavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus | Status: COMPLETED | Results posted: 2011-06-28